Testing a new flu medicine with a controlled flu infection
Part of Infections, Lungs & breathing clinical trials.
This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must be in good general health, without major medical conditions like heart, lung, or immune disorders.
- You must not have had a cold, flu, or respiratory infection in the last 4 weeks.
- You must not have had the flu or a flu vaccine in the past 6 months.
- You must not have smoked heavily (10 packs per year or more) in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This trial studies whether Apomivir works and is safe for people who likely have the flu and test positive for influenza A or B. You may help researchers learn if treating early can reduce flu illness and side effects.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.